莫西沙星在婴儿肺炎支原体脑膜炎中的药代动力学。
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.
机构信息
Department of Pediatrics, Duke University Medical Center, Durham, NC 27599, USA.
出版信息
Pediatr Infect Dis J. 2012 Feb;31(2):197-9. doi: 10.1097/INF.0b013e31823980c3.
Abstract
Treatment of Mycoplasma hominis meningitis in infants is limited by a lack of consensus regarding therapy and limited pharmacokinetic data for agents to which M. hominis is susceptible. We report the successful treatment of a premature infant suffering from M. hominis meningitis with doxycycline and moxifloxacin and provide a pharmacokinetic profile of moxifloxacin.
摘要
治疗人类支原体脑膜炎受到治疗方案缺乏共识和适合人类支原体感染的药物药代动力学数据有限的限制。我们报告了一例使用多西环素和莫西沙星成功治疗人类支原体脑膜炎的早产儿，并提供了莫西沙星的药代动力学特征。
相似文献
1
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.莫西沙星在婴儿肺炎支原体脑膜炎中的药代动力学。
Pediatr Infect Dis J. 2012 Feb;31(2):197-9. doi: 10.1097/INF.0b013e31823980c3.
2
[Moxifloxacin treatment for meningitis in an extremely preterm infant].[莫西沙星治疗极早产儿脑膜炎]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):432-436. doi: 10.7499/j.issn.1008-8830.2312016.
3
The Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid Following Intravenous Administration: A Report of Successfully Treated Infant with Mycoplasma hominis Meningitis.莫西沙星静脉给药后脑脊液药代动力学：成功治疗人型支原体脑膜炎婴儿的报告。
Pediatr Infect Dis J. 2020 Aug;39(8):e183-e184. doi: 10.1097/INF.0000000000002655.
4
[Mycoplasma hominis meningitis in a premature baby with hydrocephalus].[一名患有脑积水的早产儿的人型支原体脑膜炎]
Ugeskr Laeger. 2005 May 30;167(22):2416-7.
5
Successful treatment of post-neurosurgical intracranial Mycoplasma hominis infection using gatifloxacin.加替沙星成功治疗神经外科术后颅内人型支原体感染
J Infect. 2008 Oct;57(4):344-6. doi: 10.1016/j.jinf.2008.06.022. Epub 2008 Aug 15.
6
Successful Whole Genome Sequencing-guided Treatment of Mycoplasma hominis Ventriculitis in a Preterm Infant.全基因组测序指导治疗早产儿人型支原体脑室炎炎成功。
Pediatr Infect Dis J. 2019 Jul;38(7):749-751. doi: 10.1097/INF.0000000000002306.
7
Mycoplasma hominis meningitis in a neonate: case report and review.新生儿人型支原体脑膜炎：病例报告及文献复习
J Infect. 2008 Oct;57(4):338-43. doi: 10.1016/j.jinf.2008.08.002. Epub 2008 Sep 14.
8
Plasma and cerebrospinal fluid pharmacokinetics of moxifloxacin in a patient with tuberculous meningitis.莫西沙星在一名结核性脑膜炎患者中的血浆和脑脊液药代动力学。
Antimicrob Agents Chemother. 2008 Jun;52(6):2293-5. doi: 10.1128/AAC.01637-07. Epub 2008 Mar 24.
9
Pharmacokinetics of subconjunctival injection of moxifloxacin in humans.
Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):1019-20. doi: 10.1007/s00417-012-2036-2. Epub 2012 May 3.
10
A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia.患者患有溶血性贫血和发热，从其体内分离出一种新型血源性支原体（hemoplasma）。
Clin Infect Dis. 2011 Dec;53(11):e147-51. doi: 10.1093/cid/cir666. Epub 2011 Oct 21.
引用本文的文献
1
[Moxifloxacin treatment for meningitis in an extremely preterm infant].[莫西沙星治疗极早产儿脑膜炎]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Apr 15;26(4):432-436. doi: 10.7499/j.issn.1008-8830.2312016.
2
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.2023 年美国疾病预防控制中心炭疽病预防和治疗指南。
MMWR Recomm Rep. 2023 Nov 17;72(6):1-47. doi: 10.15585/mmwr.rr7206a1.
3
Use of Antibiotics in Preterm Newborns.早产儿抗生素的使用
Antibiotics (Basel). 2022 Aug 23;11(9):1142. doi: 10.3390/antibiotics11091142.
4
Population Pharmacokinetics of Moxifloxacin in Children.莫西沙星在儿童中的群体药代动力学
Paediatr Drugs. 2022 Mar;24(2):163-173. doi: 10.1007/s40272-022-00493-3. Epub 2022 Mar 14.
5
A Case Report of Subdural Empyema Following Decompressive Craniotomy, and a Review of Central Nervous System Infections.减压性开颅术后硬膜下积脓病例报告及中枢神经系统感染综述
Front Med (Lausanne). 2022 Feb 24;9:792323. doi: 10.3389/fmed.2022.792323. eCollection 2022.
6
Therapeutic Drug Monitoring of Moxifloxacin to Guide Treatment of Meningitis in an Extremely Preterm Infant.莫西沙星的治疗药物监测以指导极低出生体重儿脑膜炎的治疗
J Pediatr Pharmacol Ther. 2021;26(8):857-862. doi: 10.5863/1551-6776-26.8.857. Epub 2021 Nov 10.
7
Mycoplasma hominis meningitis in an extremely preterm newborn: a case report.人型支原体脑膜炎一例报告：极低出生体重儿病例
BMC Pediatr. 2021 Feb 8;21(1):69. doi: 10.1186/s12887-021-02532-3.
8
Successful Whole Genome Sequencing-guided Treatment of Mycoplasma hominis Ventriculitis in a Preterm Infant.全基因组测序指导治疗早产儿人型支原体脑室炎炎成功。
Pediatr Infect Dis J. 2019 Jul;38(7):749-751. doi: 10.1097/INF.0000000000002306.
9
Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates.基于药代动力学-药效学的抗菌药物剂量优化用于治疗新生儿革兰氏阴性菌感染的证据评估。
Indian J Med Res. 2017 Mar;145(3):299-316. doi: 10.4103/ijmr.IJMR_723_15.
10
Mycoplasma hominis Meningitis in a Full-Term Neonate: Rapid Recovery without Specific Treatment.足月新生儿人型支原体脑膜炎：未经特殊治疗迅速康复
Indian J Pediatr. 2016 Sep;83(9):1030-1. doi: 10.1007/s12098-016-2116-0. Epub 2016 Apr 25.
本文引用的文献
1
In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.20 多年来德国分离的人型支原体和脲原体对四环素类、大环内酯类、氟喹诺酮类和克林霉素的体外活性。
Clin Microbiol Infect. 2010 Nov;16(11):1649-55. doi: 10.1111/j.1469-0691.2009.03155.x.
2
Mycoplasma hominis meningitis in a neonate: case report and review.新生儿人型支原体脑膜炎：病例报告及文献复习
J Infect. 2008 Oct;57(4):338-43. doi: 10.1016/j.jinf.2008.08.002. Epub 2008 Sep 14.
3
A case of Mycoplasma hominis meningo-encephalitis in a full-term infant: rapid recovery after start of treatment with ciprofloxacin.一例足月婴儿人型支原体脑膜脑炎：开始用环丙沙星治疗后迅速康复。
Eur J Pediatr. 2003 Jul;162(7-8):514-516. doi: 10.1007/s00431-003-1219-6. Epub 2003 May 10.
4
The use of in vitro pharmacodynamic models of infection to optimize fluoroquinolone dosing regimens.
J Antimicrob Chemother. 2000 Aug;46(2):163-70. doi: 10.1093/jac/46.2.163.
5
Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man.莫西沙星在人体口服和静脉给药后的药代动力学及消除情况。
J Antimicrob Chemother. 1999 May;43 Suppl B:83-90. doi: 10.1093/jac/43.suppl_2.83.
6
Bactericidal properties of moxifloxacin and post-antibiotic effect.
J Antimicrob Chemother. 1999 May;43 Suppl B:43-9. doi: 10.1093/jac/43.suppl_2.43.
7
The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.统计矩理论在体内溶出时间和吸收时间评估中的应用。
J Pharmacokinet Biopharm. 1980 Oct;8(5):509-34. doi: 10.1007/BF01059549.
8
Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals.诺氟沙星诱发幼年动物关节病的毒代动力学研究。
Toxicol Appl Pharmacol. 1990 Sep 15;105(3):403-12. doi: 10.1016/0041-008x(90)90144-j.
9
Seizures occurring in pediatric patients receiving continuous infusion of bupivacaine.
Anesth Analg. 1992 Aug;75(2):284-6. doi: 10.1213/00000539-199208000-00023.
Zotero 插件